应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IND Xtrackers Nifty 500 India ETF
六月节休市 06-18 16:00:00 EDT
22.87
+0.23
+1.01%
盘后
22.88
+0.01
+0.04%
17:19 EDT
最高
22.96
最低
22.87
成交量
504.00
今开
22.96
昨收
22.64
日振幅
0.42%
总市值
457.30万
流通市值
457.30万
总股本
20.00万
成交额
1.15万
换手率
0.25%
流通股本
20.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
星巴克(SBUX.US)加码印度市场:计划每年新增百家门店,CEO称“扩张优先于盈利”
智通财经 · 06-18 14:53
星巴克(SBUX.US)加码印度市场:计划每年新增百家门店,CEO称“扩张优先于盈利”
德琪医药-B(06996):ATG-201 (CD19×CD3 TCE)治疗自身免疫性疾病的IND于中国获批
智通财经 · 06-10
德琪医药-B(06996):ATG-201 (CD19×CD3 TCE)治疗自身免疫性疾病的IND于中国获批
奇瑞澄清:没有在印度市场直接投资和技术转让
中国新闻网 · 06-08
奇瑞澄清:没有在印度市场直接投资和技术转让
奇瑞发布澄清声明:没有在印度市场直接投资和技术转让等安排
北京商报 · 06-08
奇瑞发布澄清声明:没有在印度市场直接投资和技术转让等安排
奇瑞:与塔塔集团合作为零部件供应,没有在印度市场直接投资和技术转让等安排
新浪科技 · 06-08
奇瑞:与塔塔集团合作为零部件供应,没有在印度市场直接投资和技术转让等安排
奇瑞汽车:奇瑞没有在印度市场直接投资和技术转让等安排 网传报道与事实不符
第一财经 · 06-08
奇瑞汽车:奇瑞没有在印度市场直接投资和技术转让等安排 网传报道与事实不符
港股异动 | 长风药业(02652)涨超5% 近日ICF004吸入粉雾剂I类新药IND申请获NMPA批准
智通财经 · 06-04
港股异动 | 长风药业(02652)涨超5% 近日ICF004吸入粉雾剂I类新药IND申请获NMPA批准
为救外汇储备 印度央行被曝抛售120亿美元黄金
智通财经 · 06-02
为救外汇储备 印度央行被曝抛售120亿美元黄金
印度股市创1月以来最长连跌行情
环球市场播报 · 06-02
印度股市创1月以来最长连跌行情
IMAX(IMAX)新增激光影厅布局 持续深耕印度市场
金吾财讯 · 06-01
IMAX(IMAX)新增激光影厅布局 持续深耕印度市场
长风药业(02652):NMPA批准ICF004 I类新药IND申请
智通财经网 · 06-01
长风药业(02652):NMPA批准ICF004 I类新药IND申请
晶泰科技收到DoveTree第二笔付款,首个肿瘤项目推进至IND-enabling研究阶段
经济参考网 · 05-31
晶泰科技收到DoveTree第二笔付款,首个肿瘤项目推进至IND-enabling研究阶段
巴克莱:印度央行6月份可能按兵不动
环球市场播报 · 05-25
巴克莱:印度央行6月份可能按兵不动
年内跌超7%成亚洲最差货币!卢比跌至历史新低,印度央行紧急入场“抛美元”救市
智通财经 · 05-20
年内跌超7%成亚洲最差货币!卢比跌至历史新低,印度央行紧急入场“抛美元”救市
港股异动 | 宜明昂科-B(01541)尾盘涨超6% IMM0306原发性干燥综合征IND申请正式获批
智通财经 · 05-19
港股异动 | 宜明昂科-B(01541)尾盘涨超6% IMM0306原发性干燥综合征IND申请正式获批
高盛:印度股市外资流出接近尾声,但外资买入仍将受限
环球市场播报 · 05-11
高盛:印度股市外资流出接近尾声,但外资买入仍将受限
中慧生物-B(02627):中国药审中心批准MRNA RSV疫苗IND申请
智通财经 · 05-08
中慧生物-B(02627):中国药审中心批准MRNA RSV疫苗IND申请
机构:油价 “负面杀伤力” 拖累印度股市
环球市场播报 · 05-08
机构:油价 “负面杀伤力” 拖累印度股市
油价飙升推动印度卢比跌至历史新低 分析师:央行或重启2013年干预“剧本”
智通财经 · 05-05
油价飙升推动印度卢比跌至历史新低 分析师:央行或重启2013年干预“剧本”
港股异动 | 三生制药(01530)现涨超5% SSS68注射液三项适应症获中国IND批准
智通财经 · 04-30
港股异动 | 三生制药(01530)现涨超5% SSS68注射液三项适应症获中国IND批准
加载更多
公司概况
公司名称:
Xtrackers Nifty 500 India ETF
所属市场:
NASDAQ
上市日期:
--
主营业务:
荷兰国际集团是在1991年由荷兰国民人寿保险公司和荷兰邮政银行集团合并组成的综合性财政金融集团。据美国财富(FORTUNES)杂志统计,以资产净值计算,荷兰国际集团位居全球500家大企业的第64位。在提供综合性金融财经业务方面(银行与保险业务),居世界第三位。目前,该集团在世界上65个国家和地区设有分支机构,雇员超过10万人。2000年,该集团取得税后净利润49亿欧元,同比增长24%。截至2000年底,集团资产总额达5030亿欧元。 管理结构: 在董事会下面设有四个管理运作核心,荷兰总部;国际金融财经业务部;企业和资本市场部;资产管理部。 集团总部:负责荷兰本国市场上的全部保险和银行业务。 国际金融财经业务部:所有荷兰本土以外的国际保险业、零售银行业和商业银行业的运作皆由该中心管理。其保险业务划分三大地区:欧洲和拉丁美洲、北美洲、亚澳地区。银行业务则由中心统一管理。 企业及资本市场部:所有国际货币和资本市场管理部门都由该部门管理。包括国际银行网络以及金融产品、贸易、销售、投资银行、企业银行、风险管理及调研的各项业务。 资产管理部:该部门承担企业投资者的资产和帐目管理、提供个人国际银行服务以及集团公司的保险业务的资产管理。房地产业务和信托业务也属于这个部门管理。该部门同时管理荷兰国际集团各个公司的投资基金。
发行价格:
--
{"stockData":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":22.865,"timestamp":1781812800000,"preClose":22.63725,"halted":0,"volume":504,"hourTrading":{"tag":"盘后","latestPrice":22.875,"preClose":22.865,"latestTime":"17:19 EDT","volume":24,"amount":553.26,"timestamp":1781817565978,"change":0.01,"changeRate":0.000437,"amplitude":0},"delay":0,"changeRate":0.010060851030933385,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"六月节休市","change":0.22775,"latestTime":"06-18 16:00:00 EDT","open":22.9599,"high":22.9599,"low":22.865,"amount":11547,"amplitude":0.004192,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":22.63725,"sharesOutstanding":200001,"nav":22.917,"aum":4583510.33,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":22.875,"preClose":22.865,"latestTime":"17:19 EDT","volume":24,"amount":553.26,"timestamp":1781817565978,"change":0.01,"changeRate":0.000437,"amplitude":0},"volumeRatio":0.48064568694106313},"requestUrl":"/m/hq/s/IND","defaultTab":"news","newsList":[{"id":"2644866770","title":"星巴克(SBUX.US)加码印度市场:计划每年新增百家门店,CEO称“扩张优先于盈利”","url":"https://stock-news.laohu8.com/highlight/detail?id=2644866770","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644866770?lang=zh_cn&edition=full","pubTime":"2026-06-18 14:53","pubTimestamp":1781765627,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,尽管全球业务面临调整压力,星巴克正在印度市场按下加速键。这家咖啡巨头与印度塔塔集团的合资企业塔塔星巴克计划每年在印度新增50至100家门店,全力抢占这个全球人口最多国家的咖啡市场增长红利。过去四到五年间,星巴克在印度的门店数量已翻倍增长至超过500家,市场份额维持在约30%。亏损中坚持投入,本土化应对竞争尽管塔塔星巴克目前仍处于亏损状态,但达什明确表示公司不会“为了盈利而牺牲增长”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["INDL","BK4523","INDA","BK4585","BK4209","IE00B3T34201.USD","INQQ","BK4588","BK4535","SCIN","INCO","GLIN","BK4610","SBUX","BK4504","NDIA","NFTY","LU0823411888.USD","INDE","IND","EPI","FLIN","SBU","INDY","PIN","LU0882574139.USD","SMIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642418288","title":"德琪医药-B(06996):ATG-201 (CD19×CD3 TCE)治疗自身免疫性疾病的IND于中国获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2642418288","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642418288?lang=zh_cn&edition=full","pubTime":"2026-06-10 06:21","pubTimestamp":1781043675,"startTime":"0","endTime":"0","summary":"智通财经APP讯,德琪医药-B(06996)发布公告,中国国家药品监督管理局(国家药监局)已批准ATG-201 (一款CD19/CD3双特异性T细胞衔接器抗体,用于治疗B细胞介导的自身免疫性疾病)的I期研究的新药临床试验(IND)申请。德琪医药计划迅速启动并推进在中国的I期研究,同时正为ATG-201在澳大利亚的临床开发作准备。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","06996","IND","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641290481","title":"奇瑞澄清:没有在印度市场直接投资和技术转让","url":"https://stock-news.laohu8.com/highlight/detail?id=2641290481","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641290481?lang=zh_cn&edition=full","pubTime":"2026-06-08 20:06","pubTimestamp":1780920389,"startTime":"0","endTime":"0","summary":"中新网北京6月8日电近日“奇瑞汽车要进入印度造车”传闻引发市场关注。8日,奇瑞汽车发布一份澄清声明称,部分媒体和账号所称的“技术出口”“技术输出”等表述,均与事实不符。图片来源:奇瑞汽车官方微博奇瑞汽车在声明中称,关注到近日许多媒体援引外媒信息,解读奇瑞与印度塔塔集团的相关合作,其中不乏善意的关心,但也衍生出大量不实猜测。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606083763824340.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763824340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["INDE","INDA","EPI","SCIN","NFTY","NDIA","INDL","BK4588","INCO","BK4523","SMIN","INQQ","GLIN","PIN","BK4585","IND","INDY","FLIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641310001","title":"奇瑞发布澄清声明:没有在印度市场直接投资和技术转让等安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2641310001","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641310001?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:29","pubTimestamp":1780910968,"startTime":"0","endTime":"0","summary":"奇瑞汽车就与印度塔塔集团的相关合作发布澄清声明称,近日许多媒体援引外媒信息,解读奇瑞与印度塔塔集团的相关合作,其中不乏善意的关心,但也衍生出大量不实猜测。奇瑞方面指出,奇瑞与印度塔塔集团正在商谈的合作协议,限定为车型相关的零部件供应,为其提供汽车散件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606083763678034.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763678034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IND","NFTY","INCO","NDIA","SCIN","PIN","BK4588","INDY","INDA","INQQ","BK4523","INDE","FLIN","SMIN","EPI","INDL","GLIN","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641447100","title":"奇瑞:与塔塔集团合作为零部件供应,没有在印度市场直接投资和技术转让等安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2641447100","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641447100?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:14","pubTimestamp":1780910040,"startTime":"0","endTime":"0","summary":"新浪科技讯 6月8日下午消息,针对与印度塔塔集团的合作,奇瑞汽车今日发布声明称,正在商谈的合作协议限定为车型相关的零部件供应,为其提供汽车散件,奇瑞没有在印度市场直接投资和技术转让等安排。奇瑞没有在印度市场直接投资和技术转让等安排,部分媒体和账号所称的“平台转让”“平台授权”“技术授权”“技术出口”“技术输出”等表述,均与事实不符。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-08/doc-iniaswmk8655156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SMIN","BK4585","EPI","IND","INDA","SCIN","GLIN","INDE","INCO","BK4523","INDL","INQQ","NFTY","FLIN","INDY","BK4588","NDIA","PIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641107735","title":"奇瑞汽车:奇瑞没有在印度市场直接投资和技术转让等安排 网传报道与事实不符","url":"https://stock-news.laohu8.com/highlight/detail?id=2641107735","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641107735?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:44","pubTimestamp":1780908270,"startTime":"0","endTime":"0","summary":"奇瑞汽车股份有限公司发布关于奇瑞合作事宜失实报道的澄清声明称,公司关注到,近日许多媒体援引外媒信息,解读奇瑞与印度塔塔集团的相关合作,其中不乏善意的关心,但也衍生出大量不实猜测。现就实际情况说明如下:奇瑞与印度塔塔集团正在商谈的合作协议,限定为车型相关的零部件供应,为其提供汽车散件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606083763627379.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763627379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["INCO","INDE","FLIN","INDL","INQQ","09973","SMIN","BK4523","EPI","GLIN","IND","NFTY","NDIA","SCIN","PIN","INDY","BK1119","BK4585","BK4588","INDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640613294","title":"港股异动 | 长风药业(02652)涨超5% 近日ICF004吸入粉雾剂I类新药IND申请获NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2640613294","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640613294?lang=zh_cn&edition=full","pubTime":"2026-06-04 14:19","pubTimestamp":1780553995,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,长风药业涨超5%,截至发稿,涨5.55%,报21.3港元,成交额566.32万港元。消息面上,近日,长风药业发布公告,ICF004吸入粉雾剂I类新药临床试验申请近期已获得中国国家药品监督管理局批准。该产品的IND批准标志着集团吸入创新候选药物进入临床开发阶段,是具有长远战略意义的重要里程碑。凭借潜在的全球首创作用机制,该产品采用吸入干粉给药途径,旨在将药物直接递送至肺部病变区域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","BK1191","02652","IND","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640913632","title":"为救外汇储备 印度央行被曝抛售120亿美元黄金","url":"https://stock-news.laohu8.com/highlight/detail?id=2640913632","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640913632?lang=zh_cn&edition=full","pubTime":"2026-06-02 15:49","pubTimestamp":1780386557,"startTime":"0","endTime":"0","summary":"高级印度经济学家Abhishek Gupta在一份报告中写道,在截至5月22日的两周内,印度央行可能出售了约120亿美元的黄金储备,同时购买了75亿美元的外汇资产。Gupta认为,这表明印度央行正在出售黄金。对于相关置评请求,印度央行尚未立即回应。这一疑似出售行为凸显出政策制定者对印度当前面临压力的担忧。Gupta认为,印度央行可能会在条件允许的情况下继续重建外汇储备。截至3月底,印度央行共持有880.52吨黄金,其中77%存放于国内。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FLIN","NDIA","BK4523","INDA","INQQ","BK4588","BK4585","INCO","EPI","IND","INDY","NFTY","INDL","INDE","SMIN","SCIN","PIN","IMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640994469","title":"印度股市创1月以来最长连跌行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2640994469","media":"环球市场播报","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640994469?lang=zh_cn&edition=full","pubTime":"2026-06-02 12:58","pubTimestamp":1780376280,"startTime":"0","endTime":"0","summary":"受亚洲市场普遍走弱拖累,加之美伊和谈毫无进展压制市场风险情绪,印度股市应声走低。印度国家证券交易所Nifty50指数下跌0.4%,即将迎来连续第五个交易日收跌,创下今年1月初以来最长连跌周期。HDFC银行与印度工业信贷投资银行(ICICI Bank)领跌大盘,两股跌幅均约1.1%。成分股50只个股中仅10只上涨、40只下跌。受人工智能行业变局冲击、年内持续承压的印度信息技术板块逆势走强,延续近期反弹走势。该行业细分指数大涨超3.5%,年内跌幅收窄至18%左右;而大盘基准Nifty指数年内累计跌幅近11%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:王永生","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-02/doc-inhzyxfp4544527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PIN","IMVP","EMXC","INDL","BK4523","INDE","NDIA","INQQ","EEMA","NFTY","BK4588","INCO","INDY","INDA","IND","GLIN","FLIN","BK4585","EPI","SCIN","SMIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950986","title":"IMAX(IMAX)新增激光影厅布局 持续深耕印度市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950986","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640950986?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:24","pubTimestamp":1780323873,"startTime":"0","endTime":"0","summary":"首座影厅计划 2026 年底落成,剩余两座则定于 2028 年投用,全部配备 IMAX 旗舰激光放映系统。此次合作也让 IMAX 重返海德拉巴,当地上一座 IMAX 场馆已于 2015 年停业。印度已是 IMAX 全球核心市场,近十年稳居其全球前十榜单。2025 年印度本土语言 IMAX 影片上映数量创下 11 部的新高,本土化内容成为增长主力。受合作消息影响,IMAX 盘前股价上涨 1.1%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301033","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDY","PIN","FLIN","INCO","IMAX","NDIA","INDL","SMIN","INDA","BK4585","BK4588","SCIN","INDE","GLIN","NFTY","INQQ","IND","BK4523","BK4108","EPI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640849981","title":"长风药业(02652):NMPA批准ICF004 I类新药IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2640849981","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640849981?lang=zh_cn&edition=full","pubTime":"2026-06-01 08:07","pubTimestamp":1780272425,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业 发布公告,ICF004吸入粉雾剂之I类新药临床试验申请近期已获得中国国家药品监督管理局批准。该产品拟用于治疗间质性肺病,包括但不限于特发性肺纤维化及进行性肺纤维化。ILD的特征为呼吸系统症状进行性加重及肺功能不可逆性下降,导致预后较差。该产品的IND批准标志着集团吸入创新候选药物进入临床开发阶段,是具有长远战略意义的重要里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","02652","IND"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2639007846","title":"晶泰科技收到DoveTree第二笔付款,首个肿瘤项目推进至IND-enabling研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2639007846","media":"经济参考网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639007846?lang=zh_cn&edition=full","pubTime":"2026-05-31 18:21","pubTimestamp":1780222917,"startTime":"0","endTime":"0","summary":"日前,晶泰科技(2228.HK)宣布,与创新生物制药公司DoveTreeMedicinesUnusInc.的战略合作取得重要进展,并收到第二笔付款。公开资料显示,晶泰科技系全球领先的AI+机器人药物研发平台企业;DoveTree是一家创新生物制药公司,专注于开发针对重大未满足临床需求疾病的首创新药(first-in-class)疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605313755192039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1617","BK1141","02228","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638235534","title":"巴克莱:印度央行6月份可能按兵不动","url":"https://stock-news.laohu8.com/highlight/detail?id=2638235534","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638235534?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:14","pubTimestamp":1779704058,"startTime":"0","endTime":"0","summary":"巴克莱经济学家在一份报告中写道,印度央行6月份可能按兵不动。\n 他们表示,虽然印度央行可能会上调通胀预测并下调增长预期,但该行应忽略由供应驱动的通胀上升。然而,持续的中东冲突导致能源价格在更长时间内走高,这可能意味着价格压力出现更持续的上升,从而威胁到巴克莱关于印度央行在2026年剩余时间里维持利率不变的基本假设。\n 该行补充说,对运输和其他原材料成本的溢出效应最终可能需要其加息。“对经济增长的削弱肯定会影响任何此类决定,但目前,我们更相信会出现通胀冲击,而不是增长冲击。”\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:何云","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2026-05-25/doc-inhzchzn9579350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["INDE","INDA","EPI","SCIN","NFTY","NDIA","INDL","BK4588","IMVP","INCO","BK4523","SMIN","INQQ","PIN","BK4585","IND","INDY","FLIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636814986","title":"年内跌超7%成亚洲最差货币!卢比跌至历史新低,印度央行紧急入场“抛美元”救市","url":"https://stock-news.laohu8.com/highlight/detail?id=2636814986","media":"智通财经","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636814986?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:10","pubTimestamp":1779264600,"startTime":"0","endTime":"0","summary":"智通财经APP注意到,由于高企的油价推低印度卢比汇率至历史新低,印度央行已采取干预措施以支撑疲软的卢比。据知情交易员透露,印度央行周三在境内外汇市场抛售了少量的美元。当时,卢比汇率已跌至 96.9650 的历史新低。印度央行在保卫本币方面正面临更大压力,卢比汇率今年已下跌超过 7%,成为亚洲表现最差的货币。今年以来,全球投资者已从该国股市撤出了创纪录的 230 亿美元。印度央行发言人未立即对寻求置评的电子邮件做出回应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["INDE","EPI","SCIN","UDN","NDIA","BK4588","IND","INDL","INCO","UUP","INDA","IMVP","PIN","BK4585","FLIN","NFTY","BK4523","SMIN","INQQ","INDY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636833670","title":"港股异动 | 宜明昂科-B(01541)尾盘涨超6% IMM0306原发性干燥综合征IND申请正式获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2636833670","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636833670?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:26","pubTimestamp":1779175568,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,宜明昂科-B尾盘涨超6%,截至发稿,涨5.41%,报3.7港元,成交额231.26万港元。消息面上,宜明昂科近日宣布,公司自主研发的阿沐瑞芙普α,在原发性干燥综合征适应症的新药临床试验申请已正式获得中国国家药品监督管理局批准。这一进展标志着宜明昂科在自身免疫性疾病领域的创新药物研发版图再次迎来重要突破。此次pSS适应症IND的获批,是宜明昂科“自免管线全面推进”战略的又一重要成果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK4585","IND","01541","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634402949","title":"高盛:印度股市外资流出接近尾声,但外资买入仍将受限","url":"https://stock-news.laohu8.com/highlight/detail?id=2634402949","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634402949?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:40","pubTimestamp":1778492400,"startTime":"0","endTime":"0","summary":"高盛表示,外资的大规模抛售行情大概率已经落幕,不过外资回流买入的力度或将持续受限。 印度外资组合投资者已累计抛售价值221.7亿美元的本土股票,规模已超过2025年创下的历史最高资金外流纪录。 高盛指出,油价下跌与海外资金回流之间的历史联动效应已明显减弱;同时,订单价格走高令企业盈利复苏前景不明朗。 高盛称,今年一季度印度股市外资持股比例跌至14年低位,且二十多年来首次低于印度本土机构投资者持股比例。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/world/2026-05-11/doc-inhxppii8986987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["INDY","EPI","INDA","BK4585","IMVP","PIN","SMIN","BK4523","SCIN","INCO","NFTY","EEMA","NDIA","BK4588","GLIN","IND","INQQ","EMXC","FLIN","INDL","INDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459715","title":"中慧生物-B(02627):中国药审中心批准MRNA RSV疫苗IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459715","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633459715?lang=zh_cn&edition=full","pubTime":"2026-05-08 20:57","pubTimestamp":1778245029,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中慧生物-B 发布公告,继集团于2025年11月7日获美利坚合众国食品药品监督管理局批准其于美国提交的新药临床试验申请后,国家药品监督管理局药品审评中心已批准集团自主研发的mRNA RSV疫苗候选产品的IND申请。目前在中国,RSV感染的治疗仍依赖广谱抗病毒药物及对症治疗。因此,迫切需要开发一种有效的RSV疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4534","BK4532","BK1161","BK4585","MRNA","159646","BK4533","BK4548","BK4568","MRNY","BK4139","IND","MRNX","BK4551","BK4588","02627","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633843116","title":"机构:油价 “负面杀伤力” 拖累印度股市","url":"https://stock-news.laohu8.com/highlight/detail?id=2633843116","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633843116?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:48","pubTimestamp":1778233680,"startTime":"0","endTime":"0","summary":"巴贾杰金融服务投资总裁拉克希米・艾耶表示,油价需企稳在100 美元下方,印度股市才能重拾上涨动能;目前小盘股已率先走强并步入牛市行情。\n 艾耶称:“原油仍是市场中最捉摸不定的变数,时而成为行情主角,而更多时候,原油正展现出利空拖累的负面一面。”\n 艾耶警示,印度小盘股已出现过度乐观情绪,后续行情将呈现个股分化特征。\n 她还指出,受伊朗局势影响,分析师对印度企业15%—16%的盈利增长预测并不现实;本季度将成为企业盈利的严峻考验,甚至可能触发市场回调。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:刘明亮","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/world/2026-05-08/doc-inhxerwc7602928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["INDE","DBC","OILU","BK4570","XES","IMVP","BWET","EPI","FLIN","FTXN","WTIU","DRLL","GUSH","DBE","OIH","PXE","INDA","BK4588","PXJ","UGA","EMXC","DRIP","DUG","INCO","NDIA","INDL","BNO","USE","PIN","USOI","SMIN","INDY","DBO","EEMA","BK4523","ERX","USL","GLIN","IEO","INQQ","IXC","IND","BK4585","SCIN","OILT","NFTY","VDE","DIG","OILK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633926189","title":"油价飙升推动印度卢比跌至历史新低 分析师:央行或重启2013年干预“剧本”","url":"https://stock-news.laohu8.com/highlight/detail?id=2633926189","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633926189?lang=zh_cn&edition=full","pubTime":"2026-05-05 14:44","pubTimestamp":1777963497,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,受中东冲突升级推动原油价格上涨影响,印度卢比汇率跌至历史新低,分析师开始考虑央行是否会重拾2013年的政策工具箱以支撑本币。中东冲突令能源价格居高不下,而外国投资者今年已从印度股市撤资210亿美元,超过2025年全年流出总额。当时,随着卢比跌破1美元兑60卢比,当时的历史低点,印度央行向炼油企业提供了约120亿美元资金。印度央行迄今为止一直依靠出售美元来捍卫本币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438050.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["UGA","DBC","GUSH","OILK","IMVP","INDL","PIN","IUmain","DRLL","NFTY","USE","INCO","INQQ","IND","SCIN","GLIN","BK4570","BK4585","BWET","IXC","NDIA","DIG","DRIP","INDE","OIH","OILT","EPI","OILU","USL","ERX","PXJ","DBE","BK4523","FLIN","DUG","FTXN","INDA","BK4588","SMIN","USOI","INDY","VDE","IEO","XES","DBO","BNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631577846","title":"港股异动 | 三生制药(01530)现涨超5% SSS68注射液三项适应症获中国IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2631577846","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631577846?lang=zh_cn&edition=full","pubTime":"2026-04-30 10:34","pubTimestamp":1777516454,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,三生制药现涨超5%,截至发稿,涨5.13%,报23.36港元,成交额3.02亿港元。值得一提的是,SSS68注射液是全球首个进入临床阶段的APRIL×BAFF双抗。值得注意的是,4月28日,三生制药自主研发的1类治疗用生物制品SSGJ-706注射液新药临床试验申请正式获得受理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","01530","BK1161","BK1583","BK1593","VXUS","BK4588","HK0000165453.HKD","IND"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ing.com","stockEarnings":[{"period":"1week","weight":0.0363},{"period":"1month","weight":0.0509},{"period":"3month","weight":0.079},{"period":"6month","weight":-0.0817},{"period":"1year","weight":-0.0856},{"period":"ytd","weight":-0.0773}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"荷兰国际集团是在1991年由荷兰国民人寿保险公司和荷兰邮政银行集团合并组成的综合性财政金融集团。据美国财富(FORTUNES)杂志统计,以资产净值计算,荷兰国际集团位居全球500家大企业的第64位。在提供综合性金融财经业务方面(银行与保险业务),居世界第三位。目前,该集团在世界上65个国家和地区设有分支机构,雇员超过10万人。2000年,该集团取得税后净利润49亿欧元,同比增长24%。截至2000年底,集团资产总额达5030亿欧元。 管理结构: 在董事会下面设有四个管理运作核心,荷兰总部;国际金融财经业务部;企业和资本市场部;资产管理部。 集团总部:负责荷兰本国市场上的全部保险和银行业务。 国际金融财经业务部:所有荷兰本土以外的国际保险业、零售银行业和商业银行业的运作皆由该中心管理。其保险业务划分三大地区:欧洲和拉丁美洲、北美洲、亚澳地区。银行业务则由中心统一管理。 企业及资本市场部:所有国际货币和资本市场管理部门都由该部门管理。包括国际银行网络以及金融产品、贸易、销售、投资银行、企业银行、风险管理及调研的各项业务。 资产管理部:该部门承担企业投资者的资产和帐目管理、提供个人国际银行服务以及集团公司的保险业务的资产管理。房地产业务和信托业务也属于这个部门管理。该部门同时管理荷兰国际集团各个公司的投资基金。","yearOnYearQuotes":[{"month":1,"riseRate":0.857143,"avgChangeRate":0.027152},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.031592},{"month":3,"riseRate":0.785714,"avgChangeRate":0.035422},{"month":4,"riseRate":0.571429,"avgChangeRate":0.017359},{"month":5,"riseRate":0.285714,"avgChangeRate":0.00595},{"month":6,"riseRate":0.714286,"avgChangeRate":0.006634},{"month":7,"riseRate":0.785714,"avgChangeRate":0.023298},{"month":8,"riseRate":0.4,"avgChangeRate":-0.016348},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.024108},{"month":10,"riseRate":0.785714,"avgChangeRate":0.022259},{"month":11,"riseRate":0.357143,"avgChangeRate":-0.033495},{"month":12,"riseRate":0.642857,"avgChangeRate":0.020836}],"exchange":"NASDAQ","name":"Xtrackers Nifty 500 India ETF","nameEN":"Xtrackers Nifty 500 India ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xtrackers Nifty 500 India ETF(IND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xtrackers Nifty 500 India ETF(IND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xtrackers Nifty 500 India ETF,IND,Xtrackers Nifty 500 India ETF股票,Xtrackers Nifty 500 India ETF股票老虎,Xtrackers Nifty 500 India ETF股票老虎国际,Xtrackers Nifty 500 India ETF行情,Xtrackers Nifty 500 India ETF股票行情,Xtrackers Nifty 500 India ETF股价,Xtrackers Nifty 500 India ETF股市,Xtrackers Nifty 500 India ETF股票价格,Xtrackers Nifty 500 India ETF股票交易,Xtrackers Nifty 500 India ETF股票购买,Xtrackers Nifty 500 India ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xtrackers Nifty 500 India ETF(IND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xtrackers Nifty 500 India ETF(IND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}